CBT for Insomnia With Anxiety and Depression
A Randomized Controlled Study of Cognitive Behavioral Therapy for Insomnia With Anxiety and Depression
1 other identifier
interventional
180
1 country
1
Brief Summary
Objective to explore whether cbt-i plus is more effective and feasible for patients with insomnia complicated with anxiety and depression than the traditional cognitive behavioral therapy for insomnia. Hypothesis: cbt-i plus is superior to cbt-i in efficacy and feasibility.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2020
CompletedFirst Submitted
Initial submission to the registry
September 9, 2020
CompletedFirst Posted
Study publicly available on registry
October 14, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2022
CompletedOctober 19, 2020
July 1, 2020
1.7 years
September 9, 2020
October 15, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
Change of sleep efficiency
Sleep efficiency was measured by sleep diary Sleep efficiency was measured by sleep diary
Change from Baseline Sleep efficiency at 8 weeks
Change of depressive symptoms
The measurement tool is Hamilton Depression Scale-17 items,the minimum score of the scale was 0 and the maximum score was 52. The higher the score was, the more serious the depression was.
Change from Baseline Sleep efficiency at 8 weeks
Change of anxiety symptoms
The measurement tool is Hamilton Anxiety Scale, the minimum score of the scale was 0 and the maximum score was 56. The higher the score was, the more serious the anxiety was.
Change from Baseline Sleep efficiency at 8 weeks
Study Arms (2)
intervention group
EXPERIMENTALThe study group was treated with intensive cognitive behavioral therapy for insomnia.
control group
ACTIVE COMPARATORThe control group was treated with traditional cognitive behavioral therapy for insomnia.
Interventions
Cbt-i plus program is an enhanced version of cbt-i program, which increases the response to depression and anxiety symptoms.
Cognitive behavioral therapy of insomnia is mainly aimed at correcting the bad behaviors and beliefs among the maintenance factors of insomnia, which is considered as the first-line treatment program of insomnia disorder. Cognitive behavioral therapy of insomnia mainly includes five important components: sleep restriction, secondary control, cognitive therapy, relaxation therapy and sleep hygiene.
Eligibility Criteria
You may qualify if:
- Age ≥18 years, male and female
- Meet the diagnostic criteria of DSM-5 for insomnia, the Pittsburgh Sleep Quality Index (PSQI) scale total score ≥10
- May be accompanied by depression symptoms, but currently does not meet any depression disorders diagnostic criteria,14≤HAMD-17≤23
- May be accompanied by anxiety symptoms, but currently does not meet any anxiety disorders diagnostic criteria ,14≤HAMA≤29
- Have sufficient education and understanding to complete this study to be examined and evaluated
- Voluntary participation in this clinical trial and signature of informed consent.
You may not qualify if:
- DSM-5 other sleep problems, such as apnea syndrome, restless leg syndrome
- Women who are pregnant, nursing or planning to become pregnant during the study
- Insomnia caused by alcohol or substance abuse
- Severe cognitive problems
- Patients who were previously or currently diagnosed as bipolar and related disorders, obsessive-compulsive and related disorders, schizophrenia spectrum and other psychotic disorders, trauma and stress related disorders, separation disorders, eating disorders
- Patients with history of epilepsy or other serious somatic diseases
- Persons receiving MECT treatment for nearly one month
- Excluding those who have received systemic psychotherapy for more than 3 months in a row
- The researchers believe that it is not suitable to participate in this clinical study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, 200030, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Chengmei Yuan
Shanghai Mental Health Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- The blind method of this study is evaluator blindness, that is, the evaluator does not know the grouping of subjects.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 9, 2020
First Posted
October 14, 2020
Study Start
August 1, 2020
Primary Completion
April 30, 2022
Study Completion
July 31, 2022
Last Updated
October 19, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share